Abstract

Leukemic patients are often immunocompromised due to underlying conditions, comorbidities and the effects of chemotherapy, and thus at risk for developing systemic infections. Bloodstream infection (BSI) is a severe complication in neutropenic patients, and is associated with increased mortality. BSI is routinely diagnosed with blood culture, which only detects culturable pathogens. We analyzed 27 blood samples from 9 patients with acute leukemia and suspected BSI at different time points of their antimicrobial treatment using shotgun metagenomics sequencing in order to detect unculturable and non-bacterial pathogens. Our findings confirm the presence of bacterial, fungal and viral pathogens alongside antimicrobial resistance genes. Decreased white blood cell (WBC) counts were associated with the presence of microbial DNA, and was inversely proportional to the number of sequencing reads. This study could indicate the use of high-throughput sequencing for personalized antimicrobial treatments in BSIs.

Highlights

  • The aim of this study was to characterize the microbial content of blood samples from neutropenic patients with newly diagnosed acute leukemia

  • BSI is treated with empirical broad-spectrum antimicrobials, which are often not efficient against the invading microbes due to the lack of specificity or resistance mechanisms[2]

  • Blood samples from patients with acute leukemia and suspected bloodstream infection were subjected to characterizing their microbiota using shotgun metagenomics

Read more

Summary

Objectives

The aim of this study was to characterize the microbial content of blood samples from neutropenic patients with newly diagnosed acute leukemia

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call